2011Zhonghua neifenmi daixie zazhiRequires access

Effect of recombinant human connective tissue growth factor on the expression of membrane type-1 matrix metalloproteinase and matrix metalloproteinase 2 in human osteoblasts

Guoliang Sui, Yiqun Peng, HE Yu-ling, Mu-xu Zhai, Ling‐Qing Yuan

Open publisher page 0 citations

Abstract

Human osteoblast was treated with recombinant human connective tissue growth factor (rCTGF). This experiment showed that rCTGF increased membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 protein expression in a dose- and time-depentent manner in human osteoblasts. rCTGF induced activation of p38 MAPK in human osteoblasts. p38 MAPK inhibitor SB23058 abrogated the effect of rCTGF on the expressions of membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 in human osteoblasts. Key words: Recombinant human connective tissue growth factor;  Human osteoblast;  Membrane type-1 matrix metalloproteinase;  Matrix metalloproteinase-2

About this research paper

What this paper is about

Human osteoblast was treated with recombinant human connective tissue growth factor (rCTGF). This experiment showed that rCTGF increased membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 protein expression in a dose- and time-depentent manner in human osteoblasts. rCTGF induced activation of p38 MAPK in human osteoblasts. p38 MAPK inhibitor SB23058 abrogated the effect of rCTGF on the expressions of membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 in human osteoblasts. Key words: Recombinant human connective tissue growth factor;  Human osteoblast;  Membrane type-1 matrix metalloproteinase;  Matrix metalloproteinase-2

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Human osteoblast was treated with recombinant human connective tissue growth factor (rCTGF). This experiment showed that rCTGF increased membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 protein expression in a dose- and time-depentent manner in human osteoblasts. rCTGF induced activation of p38 MAPK in human osteoblasts. p38 MAPK inhibitor SB23058 abrogated the effect of rCTGF on the expressions of membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 in human osteoblasts. Key words: Recombinant human connective tissue growth factor;  Human osteoblast;  Membrane type-1 matrix metalloproteinase;  Matrix metalloproteinase-2

Key concepts: Matrix metalloproteinase, Connective tissue, Extracellular matrix, Metalloproteinase, Matrix (chemical analysis), Matrix metalloproteinase 9, Growth factor, Tissue inhibitor of metalloproteinase

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of recombinant human connective tissue growth factor on the expression of membrane type-1 matrix metalloproteinase and matrix metalloproteinase 2 in human osteoblasts — Research Paper | ScholarLens